Abacus FCF Advisors’s Humana HUM Stock Holding History

Abacus FCF Advisors’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,665	Closed	-$1.3M	–	168
2023 Q3	$1.3M	Buy	2,665 +1,108	+71%	+$521K	0.69%	48
2023 Q2	$696K	Buy	1,557 +65	+4%	+$32.7K	0.35%	108
2023 Q1	$724K	Buy	1,492 +180	+14%	+$89K	0.39%	107
2022 Q4	$672K	Buy	+1,312	New	+$690K	0.44%	107
2021 Q2	–	Sell	-2,886	Closed	-$1.22M	–	149
2021 Q1	$1.22M	Sell	2,886 -1,914	-40%	-$764K	0.62%	63
2020 Q4	$1.94M	Sell	4,800 -450	-9%	-$187K	1.13%	43
2020 Q3	$2.27M	Buy	5,250 +1,890	+56%	+$760K	1.22%	21
2020 Q2	$1.32M	Sell	3,360 -150	-4%	-$56.1K	1.25%	28
2020 Q1	$1.04M	Sell	3,510 -348	-9%	-$117K	1.19%	42
2019 Q4	$1.43M	Buy	+3,858	New	+$1.22M	1.13%	20
2015 Q4	–	Sell	-12,062	Closed	-$2.16M	–	110
2015 Q3	$2.16M	Buy	+12,062	New	+$2.23M	1.11%	31
2015 Q2	–	Sell	-11,949	Closed	-$2.13M	–	111
2015 Q1	$2.13M	Buy	+11,949	New	+$1.89M	1.04%	72

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Abacus FCF Advisors's HUM Position: Q4 2023 in Review

Abacus FCF Advisors sold out of Humana (HUM) in Q4 2023, closing a stake of 2,665 shares — an estimated $1.3M sold.

Abacus FCF Advisors first reported a position in HUM in Q1 2015 and held it in 12 quarters. The position peaked at $2.27M in Q3 2020. 1,152 funds tracked by Wall St. Rank hold HUM as of Q4 2023.

Abacus FCF Advisors reported no remaining Humana position as of Q4 2023 after selling out during the quarter.
Abacus FCF Advisors sold 2,665 Humana shares in Q4 2023, an estimated $1.3M.
Abacus FCF Advisors first reported a position in Humana in Q1 2015 and held it in 12 quarters.
Abacus FCF Advisors's Humana position peaked at $2.27M in Q3 2020.
1,152 funds tracked by Wall St. Rank held Humana as of Q4 2023.

Based on Abacus FCF Advisors's 13F filing for Q4 2023, filed 4 Jan 2024.